Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Launched by SWOG CANCER RESEARCH NETWORK · Aug 10, 2020
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The PROBE Trial is a study that aims to find out whether adding surgery to a combination of immunotherapy drugs is more effective than just using immunotherapy alone for patients with metastatic kidney cancer, which means the cancer has spread to other parts of the body. Immunotherapy helps the body’s immune system fight cancer, and the trial will compare the outcomes of patients who have their kidney removed alongside receiving these treatments versus those who only receive the treatments without surgery.
To be eligible for this trial, participants should have a confirmed diagnosis of certain types of kidney cancer, with the primary tumor still in place, and evidence of cancer spread shown in recent scans. Patients must also be healthy enough to undergo surgery and cannot have received specific prior cancer treatments. Those who join the study can expect to receive either the immunotherapy drugs alone or with surgery, and they will be monitored closely throughout the trial. This research is important because it can help doctors understand the best approach to treat kidney cancer and improve outcomes for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • STEP 1 REGISTRATION: Participants must have a histologically proven diagnosis of clear cell or non-clear cell renal cell carcinoma. Participants with collecting duct carcinoma histology are not eligible. Participants with multifocal or bilateral tumors are eligible
- • STEP 1 REGISTRATION: Participants must have primary tumor in place
- * STEP 1 REGISTRATION: Participants must have the following scans performed, showing clinical evidence of measurable or non-measurable metastatic disease:
- • Computed tomography (CT) scan of the chest (can be performed without contrast if CT contrast cannot be given)
- • CT of abdomen and pelvis with contrast OR magnetic resonance imaging (MRI) of the abdomen and pelvis with or without contrast
- Scans must be performed within the following timeframes:
- • Treatment naive participants must have scans documenting metastatic disease completed within 90 days prior to study registration
- • Previously treated participants must have scans documenting metastatic disease completed within 90 days prior to first dose of systemic treatment
- • STEP 1 REGISTRATION: Participants with symptomatic metastases may have received palliative radiotherapy or receive palliative radiotherapy after registration
- • STEP 1 REGISTRATION: Participants must have no clear contraindications to nephrectomy
- • STEP 1 REGISTRATION: Participants must be offered the opportunity to participate in specimen bank. With participant consent, specimens must be collected and submitted via the Southwest Oncology Group (SWOG) Specimen Tracking System
- • STEP 1 REGISTRATION: Participants must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal guidelines
- • STEP 1 REGISTRATION: As part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
- • STEP 2 REGISTRATION: Participants must have at least one of the following scans performed 12 weeks (+/- 2 weeks) after starting pre-randomization treatment
- • CT scan of the chest (can be performed without contrast if CT contrast cannot be given)
- • CT of abdomen and pelvis with contrast OR MRI of the abdomen and pelvis with or without contrast Scans must be performed within 28 days prior to randomization. Response should be assessed by comparing with a CT or MRI of the chest, abdomen and pelvis obtained prior to starting pre-randomization treatment. Participants with complete response in all metastatic sites are not eligible to randomize to Step 2
- • • STEP 2 REGISTRATION: Participants must have one of the following objective statuses after 12 weeks of pre-randomization treatment
- • Stable disease
- • Partial response
- • The treating investigator believes the patient is deriving clinical benefit from systemic therapy AND have Zubrod performance status 0-1
- • STEP 2 REGISTRATION: Participants must plan to continue the immune-based therapy received during pre-randomization treatment
- • STEP 2 REGISTRATION: Participants must be randomized on or between the 11th and 14th week of protocol-directed pre-randomization treatment therapy
- * STEP 2 REGISTRATION: Participants must have received at least one of the minimum amounts of immunotherapy:
- • 2 infusions of nivolumab + 1 infusion of ipilimumab
- • 2 infusions of pembrolizumab
- • 2 infusions of avelumab
- • STEP 2 REGISTRATION: Participants must have a planned surgery date within 42 days of randomization
- • STEP 2 REGISTRATION: Participants must be a surgical candidate as determined by study urologist. The urology consult should be done within 42 days prior to randomization
- • STEP 2 REGISTRATION: Participants must have a complete physical examination and medical history within 28 days prior to randomization
- • STEP 2 REGISTRATION: Participants must have a Zubrod performance status of 0-1 within 28 days prior to randomization
- • STEP 2 REGISTRATION: Total bilirubin =\< institutional upper limit of normal (ULN) (within 28 days prior to randomization)
- • STEP 2 REGISTRATION: Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =\< 3 x institutional upper limit of normal (ULN) (within 28 days prior to randomization)
- • STEP 2 REGISTRATION: Serum creatinine =\< 1.5 x the institutional upper limit of normal (IULN) OR measured OR calculated creatinine clearance \>= 50 mL/min using the Cockcroft-Gault Formula) (must have been drawn and processed within 28 days prior to randomization)
- Exclusion Criteria:
- • STEP 1 REGISTRATION: Participants must not have known active brain metastases. Participants with previously treated brain metastases are eligible if participant has no neurologic signs or symptoms suggestive of brain metastasis. Brain imaging studies are not required. If brain imaging studies are performed, they must be negative for disease
- * STEP 1 REGISTRATION: Participants must not have received the following prior treatment of metastatic renal cell carcinoma:
- • Treatment naive participants must not have received any prior lines of systemic therapy for metastatic renal cell carcinoma beyond the line intended as part of protocol therapy
- • Previously treated participants must not have received any systemic therapy for metastatic renal cell carcinoma beyond the one regimen received off protocol as specified in Step 1 pre-randomization treatment
- * STEP 1 REGISTRATION: Participants must not have received more than the following amounts protocol-directed pre-randomization treatment:
- • Treatment naive participants must not have received any pre-randomization treatment.
- * Previously treated participants must not be planning to receive any additional treatment prior to Step 2 randomization, and must not have received more than the following amounts of pre-randomization treatment:
- • 4 infusions of nivolumab
- • 4 infusions of ipilimumab
- • 4 infusions of pembrolizumab
- • 7 infusions of avelumab
- * STEP 1 REGISTRATION: Participants must not have received immunotherapy for any cancer within the following timeframes:
- • Treatment naive participants must not have received any immunotherapy within a year of registration
- • Previously treated participants must not have received any other immunotherapy within a year of the start of off protocol specified pre-randomization treatment
- • STEP 1 REGISTRATION: Participants must not have a solitary kidney and not have a transplanted kidney
- • STEP 1 REGISTRATION: No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, any in situ or T1 cancer, adequately treated stage I or II cancer from which the participant is currently in complete remission, or any other cancer from which the participant has been disease free for at least two years
- • STEP 1 REGISTRATION: Participants must not have been previously diagnosed with a medical condition that makes them ineligible for immune based combination therapy or nephrectomy
- • STEP 2 REGISTRATION: Participants must not show progression in the primary tumor. Participants who are considered to have pseudo progression are allowed
- • STEP 2 REGISTRATION: Participants must not have known active brain metastases. Participants with previously treated brain metastases are eligible if participant has no neurologic signs or symptoms suggestive of brain metastasis. Brain imaging studies are not required. If brain imaging studies are performed, they must be negative for disease
- • STEP 2 REGISTRATION: No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated stage I or II cancer from which the participant is currently in complete remission, or any other cancer from which the participant has been disease free for two years
About Swog Cancer Research Network
The SWOG Cancer Research Network is a leading cancer clinical trial organization dedicated to improving cancer treatment and outcomes through innovative research. Comprising a collaborative network of academic institutions, community hospitals, and cancer centers, SWOG conducts rigorous clinical trials that advance the understanding of cancer biology, prevention, and therapy. With a strong emphasis on inclusivity and diversity, SWOG aims to ensure that clinical research reflects the populations affected by cancer, ultimately striving to enhance patient care and quality of life. Through its commitment to scientific excellence and collaboration, SWOG plays a pivotal role in shaping the future of oncology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Cleveland, Ohio, United States
Milwaukee, Wisconsin, United States
Charleston, South Carolina, United States
Buffalo, New York, United States
Kalamazoo, Michigan, United States
Burnsville, Minnesota, United States
Edina, Minnesota, United States
Waconia, Minnesota, United States
Maywood, Illinois, United States
Peoria, Illinois, United States
Detroit, Michigan, United States
Hackensack, New Jersey, United States
Oklahoma City, Oklahoma, United States
Duarte, California, United States
Des Moines, Iowa, United States
Saint Paul, Minnesota, United States
Ann Arbor, Michigan, United States
Kalamazoo, Michigan, United States
Traverse City, Michigan, United States
Chicago, Illinois, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Mount Vernon, Illinois, United States
Yakima, Washington, United States
Coon Rapids, Minnesota, United States
Renton, Washington, United States
Urbana, Illinois, United States
Carroll, Iowa, United States
Minneapolis, Minnesota, United States
Saint Paul, Minnesota, United States
Shakopee, Minnesota, United States
Willmar, Minnesota, United States
Dayton, Ohio, United States
Effingham, Illinois, United States
Saint Joseph, Missouri, United States
Greenville, Ohio, United States
Wisconsin Rapids, Wisconsin, United States
Springfield, Illinois, United States
Houston, Texas, United States
Downers Grove, Illinois, United States
Roseville, California, United States
Hazel Crest, Illinois, United States
Springfield, Illinois, United States
San Antonio, Texas, United States
Minneapolis, Minnesota, United States
Rochester, New York, United States
Toledo, Ohio, United States
Medford, Oregon, United States
Salt Lake City, Utah, United States
Birmingham, Alabama, United States
Tucson, Arizona, United States
Los Angeles, California, United States
Modesto, California, United States
Sacramento, California, United States
Orlando, Florida, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
New Orleans, Louisiana, United States
Saint Louis, Missouri, United States
Columbus, Ohio, United States
Pittsburgh, Pennsylvania, United States
Los Angeles, California, United States
Mountain View, California, United States
Aurora, Illinois, United States
Lexington, Kentucky, United States
Kettering, Ohio, United States
Cape Girardeau, Missouri, United States
Elmhurst, Illinois, United States
Washington, District Of Columbia, United States
Novato, California, United States
New Orleans, Louisiana, United States
Fridley, Minnesota, United States
Robbinsdale, Minnesota, United States
Saint Louis Park, Minnesota, United States
Saint Louis, Missouri, United States
Portland, Oregon, United States
Omaha, Nebraska, United States
Milwaukee, Wisconsin, United States
Grand Rapids, Michigan, United States
Oak Lawn, Illinois, United States
Park Ridge, Illinois, United States
Albuquerque, New Mexico, United States
Dallas, Texas, United States
Houston, Texas, United States
Sacramento, California, United States
Orlando, Florida, United States
Saint Louis, Missouri, United States
Las Vegas, Nevada, United States
Marshfield, Wisconsin, United States
Detroit, Michigan, United States
Reno, Nevada, United States
Decatur, Illinois, United States
Ottawa, Illinois, United States
Peoria, Illinois, United States
Galesburg, Illinois, United States
Des Moines, Iowa, United States
Des Moines, Iowa, United States
Jackson, Michigan, United States
Los Angeles, California, United States
Reed City, Michigan, United States
Cape Girardeau, Missouri, United States
Peru, Illinois, United States
Maplewood, Minnesota, United States
Maplewood, Minnesota, United States
Stillwater, Minnesota, United States
Findlay, Ohio, United States
Seneca, Pennsylvania, United States
Kalamazoo, Michigan, United States
Alton, Illinois, United States
Galesburg, Illinois, United States
Richmond, Indiana, United States
Ames, Iowa, United States
New Orleans, Louisiana, United States
Battle Creek, Michigan, United States
Grand Rapids, Michigan, United States
Saint Joseph, Michigan, United States
Woodbury, Minnesota, United States
Joplin, Missouri, United States
Springfield, Missouri, United States
Springfield, Missouri, United States
Reno, Nevada, United States
Boardman, Ohio, United States
Cincinnati, Ohio, United States
Dayton, Ohio, United States
Franklin, Ohio, United States
Mentor, Ohio, United States
Troy, Ohio, United States
Warren, Ohio, United States
Youngstown, Ohio, United States
Portland, Oregon, United States
Minocqua, Wisconsin, United States
Rice Lake, Wisconsin, United States
Sheboygan, Wisconsin, United States
Wausau, Wisconsin, United States
West Allis, Wisconsin, United States
Weston, Wisconsin, United States
Kettering, Ohio, United States
Berkeley, California, United States
Mountain View, California, United States
Palo Alto, California, United States
San Francisco, California, United States
Naperville, Illinois, United States
Springfield, Ohio, United States
Libertyville, Illinois, United States
Oshkosh, Wisconsin, United States
New Ulm, Minnesota, United States
Castro Valley, California, United States
Tucson, Arizona, United States
Saint Joseph, Michigan, United States
Las Vegas, Nevada, United States
Elgin, Illinois, United States
Goldsboro, North Carolina, United States
Chippewa Falls, Wisconsin, United States
Canton, Illinois, United States
Carthage, Illinois, United States
Eureka, Illinois, United States
Kewanee, Illinois, United States
Macomb, Illinois, United States
Peru, Illinois, United States
Princeton, Illinois, United States
Warrenville, Illinois, United States
Niles, Michigan, United States
Joplin, Missouri, United States
Lake Success, New York, United States
Grafton, Wisconsin, United States
Greenville, South Carolina, United States
Greenville, South Carolina, United States
Fort Smith, Arkansas, United States
Vallejo, California, United States
Bloomington, Illinois, United States
Chicago, Illinois, United States
Geneva, Illinois, United States
Pekin, Illinois, United States
Bolivar, Missouri, United States
Branson, Missouri, United States
Saint Louis, Missouri, United States
Erie, Pennsylvania, United States
Boiling Springs, South Carolina, United States
Easley, South Carolina, United States
Greenville, South Carolina, United States
Greenville, South Carolina, United States
Greer, South Carolina, United States
Seneca, South Carolina, United States
Burlington, Wisconsin, United States
Germantown, Wisconsin, United States
Green Bay, Wisconsin, United States
Kenosha, Wisconsin, United States
Marinette, Wisconsin, United States
Milwaukee, Wisconsin, United States
Racine, Wisconsin, United States
Summit, Wisconsin, United States
Two Rivers, Wisconsin, United States
Wauwatosa, Wisconsin, United States
Auburn, California, United States
Cameron Park, California, United States
Roseville, California, United States
Vacaville, California, United States
Saint Johnsbury, Vermont, United States
South Pasadena, California, United States
Mckeesport, Pennsylvania, United States
Los Angeles, California, United States
Santa Rosa, California, United States
Arroyo Grande, California, United States
Jefferson City, Missouri, United States
Oklahoma City, Oklahoma, United States
Dearborn, Michigan, United States
Sunnyvale, California, United States
West Des Moines, Iowa, United States
Baton Rouge, Louisiana, United States
Rolla, Missouri, United States
Rolla, Missouri, United States
Beachwood, Ohio, United States
Bellevue, Washington, United States
New Richmond, Wisconsin, United States
Urbana, Illinois, United States
Springfield, Illinois, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Springfield, Ohio, United States
Beaver, Pennsylvania, United States
Greensburg, Pennsylvania, United States
Johnstown, Pennsylvania, United States
Natrona Heights, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Auburn, California, United States
Davis, California, United States
Santa Cruz, California, United States
Garden City, Kansas, United States
Great Bend, Kansas, United States
Minneapolis, Minnesota, United States
Henderson, Nevada, United States
Henderson, Nevada, United States
Henderson, Nevada, United States
Henderson, Nevada, United States
Henderson, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Clinton, North Carolina, United States
Jacksonville, North Carolina, United States
Centerville, Ohio, United States
West Chester, Ohio, United States
Altamonte Springs, Florida, United States
Kissimmee, Florida, United States
Orlando, Florida, United States
Orlando, Florida, United States
Winter Park, Florida, United States
Carbondale, Illinois, United States
Carterville, Illinois, United States
Centralia, Illinois, United States
Danville, Illinois, United States
Decatur, Illinois, United States
Effingham, Illinois, United States
Mattoon, Illinois, United States
New Lenox, Illinois, United States
O'fallon, Illinois, United States
Yorkville, Illinois, United States
Brownstown, Michigan, United States
Clinton Township, Michigan, United States
Novi, Michigan, United States
West Bloomfield, Michigan, United States
Maple Grove, Minnesota, United States
Wyoming, Minnesota, United States
Sainte Genevieve, Missouri, United States
Sullivan, Missouri, United States
Sunset Hills, Missouri, United States
Centerville, Ohio, United States
Cincinnati, Ohio, United States
Dayton, Ohio, United States
Findlay, Ohio, United States
Findlay, Ohio, United States
Franklin, Ohio, United States
Greenville, Ohio, United States
Ames, Iowa, United States
Boone, Iowa, United States
Fort Dodge, Iowa, United States
Jefferson, Iowa, United States
Marshalltown, Iowa, United States
Gulfport, Mississippi, United States
Henderson, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Norton Shores, Michigan, United States
Monticello, Minnesota, United States
Carson City, Nevada, United States
Henderson, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Reno, Nevada, United States
Eau Claire, Wisconsin, United States
Stevens Point, Wisconsin, United States
Wyandotte, Michigan, United States
Ladysmith, Wisconsin, United States
Fremont, California, United States
Milwaukee, Wisconsin, United States
Menomonee Falls, Wisconsin, United States
West Bend, Wisconsin, United States
Des Moines, Iowa, United States
Pasadena, California, United States
Orland Park, Illinois, United States
Plainfield, Illinois, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Metairie, Louisiana, United States
Fort Worth, Texas, United States
Gilbert, Arizona, United States
Dekalb, Illinois, United States
Henderson, Nevada, United States
Las Vegas, Nevada, United States
Pahrump, Nevada, United States
Beavercreek, Ohio, United States
Stevens Point, Wisconsin, United States
Metairie, Louisiana, United States
Ballwin, Missouri, United States
Washington, Missouri, United States
Newport Beach, California, United States
Fort Dodge, Iowa, United States
Burr Ridge, Illinois, United States
Farrell, Pennsylvania, United States
Lake Forest, Illinois, United States
Brighton, Michigan, United States
Altoona, Pennsylvania, United States
Oak Creek, Wisconsin, United States
Libertyville, Illinois, United States
Kingman, Arizona, United States
Dixon, Illinois, United States
Washington, Illinois, United States
Farmington, Missouri, United States
Henderson, Nevada, United States
Henderson, Nevada, United States
Henderson, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
Las Vegas, Nevada, United States
San Mateo, California, United States
Tarzana, California, United States
Upland, California, United States
Burnsville, Minnesota, United States
Salt Lake City, Utah, United States
Celebration, Florida, United States
Shelby, Michigan, United States
Cambridge, Minnesota, United States
Princeton, Minnesota, United States
Barrington, Illinois, United States
Crystal Lake, Illinois, United States
Kalamazoo, Michigan, United States
Omaha, Nebraska, United States
Omaha, Nebraska, United States
Sleepy Hollow, New York, United States
Butler, Pennsylvania, United States
Indiana, Pennsylvania, United States
Monroeville, Pennsylvania, United States
Mount Pleasant, Pennsylvania, United States
N. Huntingdon, Pennsylvania, United States
New Castle, Pennsylvania, United States
Uniontown, Pennsylvania, United States
Washington, Pennsylvania, United States
West Mifflin, Pennsylvania, United States
Richardson, Texas, United States
Melrose Park, Illinois, United States
Homer Glen, Illinois, United States
Huntington Beach, California, United States
Salt Lake City, Utah, United States
Clackamas, Oregon, United States
Avon, Ohio, United States
Buena Park, California, United States
Los Angeles, California, United States
Clinton Township, Michigan, United States
Dallas, Texas, United States
Lebanon, New Hampshire, United States
Wyoming, Michigan, United States
Grand Rapids, Michigan, United States
Muskegon, Michigan, United States
Troy, Ohio, United States
Centralia, Illinois, United States
Danville, Illinois, United States
Boone, Iowa, United States
Fort Dodge, Iowa, United States
Jefferson, Iowa, United States
Marshalltown, Iowa, United States
Ames, Iowa, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials